MitoWorld

In “Beyond the Disease” MitoWorld partners with the United Mitochondrial Disease Foundation to highlight advances in mitochondrial science and the people responsible for them. www.MitoWorld.org is devoted to better public and medical understanding of underlying mitochondrial science in an effort to raise awareness of the field in order to attract greater funding for the pursuit of mitochondrial disease and dysfunction.

Dr. A Phillip West, Ph.D. announced as new board member of MitoWorld’s parent nonprofit, the National Laboratory for Education Transformation. Dr. West is Associate Professor and Principal Investigator at the Jackson Laboratory in Bar Harbor, ME where The West Lab is located.

In May, a FUSION Conference will bring mitochondrial and STEM cell biologists to Malta. Entitled “Mitochondria & Cell Fate Transitions: From Stemness to Senescence,” the conference will connect mitochondrial dynamics, metabolism, redox signaling, and organelle communication with cell-fate decisions. This highly interactive meeting will allow plenty time for interactions between experienced and early-career investigators.

Mitochondrion, Bringing Computational Capacity to Mitochondrial Research

MitoWorld.org announces a new partnership with Heureka Labs, an AI-driven discovery platform with roots at Duke University, aimed at fundamentally expanding the analytical and discovery capacity of the global mitochondrial research community.

A new multi-gene approach to pathway mapping to identify complex II as a central regulator of de novo purine biosynthesis...

A recent paper in Nature Metabolism, an international research group, led by Matthew Hirschey Kris Wood of Duke University and Alexandre Puissant of the Saint-Louis Research Institute/Hospital, INSERM in Paris, report a multi-gene approach to pathway mapping. Using this tool, they identified complex II as a central regulator of de novo purine biosynthesis and a promising therapeutic target for acute myeloid leukemia.

Beyond The Disease, February 4, 2026